Cancer Tx Eye Toxicity; ASCO Targets Preauthorization; Liver Transplant for Seniors
(MedPage Today) --
Neoadjuvant immunotherapy for aggressive breast cancer benefited all patients, regardless of race. (American Association for Cancer Research)
Treatments for genitourinary cancers have a risk of a wide range of ophthalmologic...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hematology | Immunotherapy | Liver | Liver Transplant | Neoadjuvant Therapy | Opthalmology | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology